1-2 of 2
Bouchra Benettaib, MD
Close
Save search
Follow your search
Access your saved searches in your account
Would you like to receive an alert when new items match your search?
Close Modal
Sort by
Journal Articles

Outcomes In RBC Transfusion-Dependent Patients (Pts) With Low-/Intermediate (Int)-1-Risk Myelodysplastic Syndromes (MDS) With Isolated Deletion 5q Treated With Lenalidomide (LEN): A Subset Analysis From The MDS-004 Study

Aristoteles Giagounidis, MD, PhD, Ghulam J. Mufti, MD, PhD, Moshe Mittelman, MD, Guillermo Sanz, MD, PhD, Uwe Platzbecker, MD, PhD, Petra Muus, MD, PhD, Dominik Selleslag, MD, Odile Beyne-Rauzy, MD, PhD, Peter te Boekhorst, MD, PhD, Consuelo del Cañizo, MD, PhD, Agnès Guerci-Bresler, MD, PhD, Michael Lübbert, MD, PhD, Bruno Quesnel, MD, PhD, Arnold Ganser, MD, David Bowen, MD, PhD, Brigitte Schlegelberger, MD, PhD, Tommy Fu, Bouchra Benettaib, MD, Eva Hellström-Lindberg, MD, PhD, Pierre Fenaux, MD, PhD
Journal: Blood
Blood (2013) 122 (21): 2753.
https://doi.org/10.1182/blood.V122.21.2753.2753
Published: 2013
Journal Articles

Analysis of Second Primary Malignancies in Lenalidomide-Treated Patients with IPSS Low- or Int-1-Risk Myelodysplastic Syndromes

Aristoteles Giagounidis, MD, Azra Raza, MD, Alan F. List, MD, Pierre Fenaux, MD, PhD, Bouchra Benettaib, MD, Benton Brown, MD, Jim Zhong, PhD, Nancy Brandenburg, PhD, Ghulam J. Mufti, MD
Journal: Blood
Blood (2011) 118 (21): 1704.
https://doi.org/10.1182/blood.V118.21.1704.1704
Published: 2011